The rationale for methylene blue utility against SARS-CoV-2 infection complications
Context: Almost one year after the onset of COVID-19 pandemic in Wuhan, China and still no specific therapy has emerged, counting millions of dead worldwide. The association of an uncontrolled SARS-CoV-2 replication and host-dependent mechanisms in COVID-19 pathogenesis suggest that any therapeutic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
2021-05-01
|
| Series: | Journal of Pharmacy & Pharmacognosy Research |
| Subjects: | |
| Online Access: | https://jppres.com/jppres/pdf/vol9/jppres21.1019_9.3.379.pdf |